SENSICARDIAC vs ClearRead CT

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

SENSICARDIAC

by Diacoustic Medical Devices (Pty) Ltd.

ClearRead CT

by RIVERAIN TECHNOLOGIES

AI Verdict

These tools are adjacent rather than direct competitors, as they address different diagnostic modalities and clinical problems within cardiology. SENSICARDIAC focuses on real-time heart murmur detection using electronic stethoscopes, aiding in the initial assessment of cardiac sounds. In contrast, ClearRead CT analyzes CT scans to detect pulmonary nodules and score coronary artery calcification, providing insights from medical imaging.

Choose SENSICARDIAC if…

Choose SENSICARDIAC if your primary need is real-time, AI-assisted heart murmur detection during patient auscultation, especially in telehealth or remote monitoring scenarios. This tool is ideal for physicians seeking to quickly classify murmurs as pathological or physiological at the point of care, thereby streamlining initial diagnoses and reducing unnecessary specialist referrals.

View SENSICARDIAC →

Choose ClearRead CT if…

Choose ClearRead CT if your focus is on enhancing the accuracy and efficiency of cardiothoracic CT scan interpretation, particularly for pulmonary nodule detection and coronary artery calcification scoring. This AI suite is best suited for radiology departments aiming to reduce reading times, improve diagnostic confidence, and integrate advanced AI analysis seamlessly into their existing PACS workflows.

View ClearRead CT →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	SENSICARDIAC	ClearRead CT
Pricing	Unknown	Contact for pricing
Deployment	SensiCardiac is a software package running on a Windows PC that interfaces with compatible electronic stethoscopes. SensiCardiac Mobi runs on a mobile device (iPhone 4S or later) and interfaces with a hosted Linux server environment. The related Telesensi platform operates entirely in the browser.	On-premise (stand-alone server, virtual machine) and Cloud
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

SENSICARDIAC

SENSICARDIAC (Tool A) offers a 'guided auscultation process' and 'real-time analysis' integrated with electronic stethoscopes, suggesting a direct and intuitive workflow for clinicians performing cardiac exams. ClearRead CT (Tool B), while offering 'seamless PACS integration,' operates within a more complex radiology workflow, making Tool A's direct user interaction potentially more immediately usable for its specific function.

Clinical Value

ClearRead CT

ClearRead CT (Tool B) provides quantified clinical benefits, including a '29% reduction in missed actionable nodules' and 'improved detection accuracy' for pulmonary nodules and coronary artery calcification. While SENSICARDIAC (Tool A) aids diagnosis and reduces unnecessary referrals for heart murmurs, Tool B's specific, measurable improvements in diagnostic outcomes give it a slight edge in demonstrated clinical value.

Pricing & Value

Tie

Both SENSICARDIAC (Tool A) and ClearRead CT (Tool B) state 'contact for pricing' and do not provide publicly available pricing details. Without any information on cost structures, licensing models, or specific value-based pricing, it is impossible to compare their pricing or assess their value proposition.

Enterprise Readiness

ClearRead CT

ClearRead CT (Tool B) explicitly highlights 'seamless PACS Integration' and 'Vendor-neutral processing,' which are critical for adoption within large healthcare systems. Its deployment flexibility (on-premise and cloud) and mention of operating with 'VA and other healthcare institutions' further indicate robust enterprise readiness compared to SENSICARDIAC's (Tool A) more specific integration with electronic stethoscopes.

Innovation

SENSICARDIAC

SENSICARDIAC (Tool A) demonstrates significant innovation by offering 'LIVE diagnostic quality stethoscope streaming and AI heart murmur screening' for real-time analysis in remote cardiac care. This application of AI to live biosignal data for immediate diagnostic aid in a telehealth context represents a forward-thinking approach to patient monitoring and early intervention.

Support & Docs

Tie

Neither the provided structured facts nor readily available public web searches offer specific details regarding the support channels, documentation availability, or service level agreements for SENSICARDIAC (Tool A) or ClearRead CT (Tool B). Therefore, it is not possible to differentiate between the two on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	SENSICARDIAC	ClearRead CT
Name	SENSICARDIAC	ClearRead CT
Company	DIACOUSTIC MEDICAL (PTY)	RIVERAIN TECHNOLOGIES
Primary Function	AI-powered, cloud-based heart murmur detection service that integrates with electronic stethoscopes to classify murmurs as pathological or physiological.	FDA-cleared AI suite for cardiothoracic health, enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans.
Target Specialties	Cardiology, Internal Medicine, Pediatrics	Cardiology, Pulmonology, Radiology
Key AI Focus	Heart murmur detection and classification (Class I: dangerous pathological, Class III: innocent physiological) using electronic stethoscopes.	Pulmonary Nodule Detection (solid, part-solid, ground glass), Nodule Characterization and Measurement, Automated Nodule Tracking, and Coronary Artery Calcification (CAC) Scoring.

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC and ClearRead CT.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How does SENSICARDIAC integrate into a physician's daily workflow for cardiac assessment, and what specific clinical insights does its real-time analysis provide?

SENSICARDIAC integrates by connecting with electronic stethoscopes, offering a guided auscultation process and real-time AI analysis of heart sounds. It classifies murmurs as dangerous pathological (Class I) or innocent physiological (Class III), aiding physicians in diagnosis and potentially reducing unnecessary referrals.

Beyond basic reports, what is the depth of EHR and PACS integration for these tools to ensure seamless data flow and accessibility of AI-generated insights?

SENSICARDIAC provides downloadable PDF cardiac reports and visualizations, indicating integration for documentation. ClearRead CT offers seamless PACS integration and vendor-neutral processing, with output in DICOM format and configurable optional output formats for integration with workflow or external tools, including structured reporting and HL-7 integration.

What specific metrics and features demonstrate ClearRead CT's improved diagnostic accuracy for pulmonary nodules and its clinical utility in coronary artery calcification scoring?

ClearRead CT has shown a 29% reduction in missed actionable nodules and a 36% reduction in reading time. Its patented vessel suppression technology improves nodule conspicuity, and it provides automated nodule characterization, measurement, and tracking, along with incidental coronary artery calcification (CAC) scoring on ungated, non-contrast CTs.

For which specific medical specialties and patient populations are SENSICARDIAC and ClearRead CT most clinically relevant and beneficial?

SENSICARDIAC is designed for Cardiology, Internal Medicine, and Pediatrics, focusing on heart murmur detection and screening. ClearRead CT is primarily for Cardiology, Pulmonology, and Radiology, aiding in pulmonary nodule detection and coronary artery calcification analysis in adult patients undergoing CT scans.

What is the typical learning curve for physicians to effectively utilize each tool, and what is the expected time-to-value in terms of workflow efficiency or diagnostic improvement?

SENSICARDIAC's guided auscultation and real-time analysis suggest a relatively intuitive learning process for immediate clinical insights. ClearRead CT aims for rapid time-to-value by reducing reading times by up to 36% and improving detection accuracy, streamlining radiology workflows and enhancing diagnostic throughput.

Beyond standard compliance, what advanced security measures and audit-trail features do these tools offer to protect patient data and ensure accountability?

SENSICARDIAC, being cloud-based with live streaming, would require robust data encryption and access controls, though specific additional measures are not detailed. ClearRead CT, when integrated into hospital IT infrastructure, supports role-based authentication and authorization, and its PACS integration implies audit-trail capabilities for AI-assisted findings and user interactions, consistent with HIPAA requirements for logging activity in systems containing ePHI.